Cellid, COVID-19 vaccine Korean stock

ที่อัปเดต:
Bullish

Reasons
- Cup & handle formation
- Bounces on trendline
- Currently developing COVID-19 vaccine in Korea alongside other biotech products
- Korean government granted $30 mil to develop vaccines recently
การซื้อขายยังคงดำเนินอยู่
Prices pulled back from the initial trendline due to choppiness from falling KOSDAQ index. This was due to fears of economic shutdown from COVID-19 breakouts.

Still a go. It still has not announced a clinical trial for the COVID-19 vaccine but received money from the Korean government to develop one. If it is announced, then it is going to rocket.
การซื้อขายยังคงดำเนินอยู่
Space elevator~
ปิดการเทรด: ถึงเป้าหมายการตัดขาดทุน
Events didn't pan out as I had expected.

Too bad.
Technical IndicatorsTrend Analysis

และใน:

คำจำกัดสิทธิ์ความรับผิดชอบ